COVID-19 and musculoskeletal pain: an overview of the current knowledge

Matteo Castaldo1, Brian D Ebbesen2,3, César Fernández-DE-Las-Peñas2,4

  • 1School of Medicine, Center for Neuroplasticity and Pain, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark - matteo.castaldo@poliambulatoriofisiocenter.com.

Minerva Anestesiologica
|November 29, 2023
PubMed

Insights

Post-COVID pain affects up to 60% of survivors, with musculoskeletal issues like fatigue and joint pain being common. Understanding the complex causes and developing targeted treatments for this persistent pain is crucial.

Area of Science:

  • * Infectious Diseases and Immunology
  • * Rheumatology and Musculoskeletal Medicine

Background:

  • * Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to widespread infections globally.
  • * A significant percentage of COVID-19 survivors experience persistent post-COVID symptoms, including pain, lasting up to a year.
  • * Musculoskeletal pain, manifesting as fatigue, myalgia, and arthralgia, is a prevalent post-COVID condition, affecting 10-60% of individuals.

Purpose of the Study:

  • * To review the clinical features, underlying mechanisms, and potential management strategies for musculoskeletal post-COVID pain.
  • * To emphasize the need for further research into the complex pathophysiology of post-COVID musculoskeletal pain.
  • * To discuss the current controversies and general approaches in managing this condition.

Main Methods:

  • * Literature review and synthesis of existing studies on post-COVID pain.
  • * Analysis of reported clinical manifestations and proposed pathophysiological mechanisms.
  • * Examination of current treatment modalities and guidelines for musculoskeletal pain.

Main Results:

  • * Musculoskeletal pain is a highly prevalent symptom in post-COVID condition, with significant impact on survivors.
  • * The exact mechanisms driving musculoskeletal post-COVID pain are not fully understood, with contributions from immune, biological, psychological, genetic, and epigenetic factors.
  • * Management strategies are not standardized, with a general recommendation for multidisciplinary and multimodal approaches.

Conclusions:

  • * Musculoskeletal pain is a significant and complex sequela of COVID-19 requiring further investigation.
  • * A comprehensive understanding of the multifactorial mechanisms is essential for developing effective treatments.
  • * Multidisciplinary and multimodal treatment approaches are currently recommended for managing post-COVID musculoskeletal pain.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
966
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
632
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Blood and Nerve Supply to the Bones01:29

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
11.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.5K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.2K